UNSPSC 51181624: Calcitonin human

This classification denotes a peptide hormone with the molecular formula C151H226N40O45S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0IO929019, chemically known as calcitonin (human) [mart.], but more generally known as calcitonin human, which bears US NIH Compound Identifier 16132288. European Medicines Agency schedules calcitonin human or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00948MIG. Most nations, for tariff purposes, schedule calcitonin human under HS 29371900. SMILES:.

Calcitonin human bears US NLM identifiers UMLS ID C0770558 and NCI Concept Code C77142.

UNSPSC 51181624 Calcitonin human is a Commodity code for a synthetic hormone medication used primarily to treat hypercalcemia, osteoporosis, and Paget's disease. State and local governments procure calcitonin human through their pharmacy benefit programs and direct institutional purchases for public hospitals, correctional facilities, and long-term care operations. The medication is typically sourced as an injectable pharmaceutical product and may be procured as a single-source item or through competitive bidding when multiple manufacturers or suppliers qualify. Issuing bodies include state Medicaid agencies, county health departments, municipal hospital systems, state correctional departments, and standalone correctional healthcare providers.

The provided source contains no recent state or local contract opportunities tagged to UNSPSC 51181624. Without posted solicitations, representative geographic activity, issuing-body concentration, or recent RFP, RFQ, IFB, or ITB records, no basis exists to characterize current procurement velocity, regional concentration, or near-term buying intent under this code.